Search Articles

View query in Help articles search

Search Results (1 to 10 of 2048 Results)

Download search results: CSV END BibTex RIS


Continuous Noninvasive Remote Automated Blood Pressure Monitoring With Novel Wearable Technology: A Preliminary Validation Study

Continuous Noninvasive Remote Automated Blood Pressure Monitoring With Novel Wearable Technology: A Preliminary Validation Study

Vitaliti CVSM activity intensities were empirically derived during data collection; a critical threshold of 2.4 gravities per second (g/s) represented “vigorous patient activity,” equivalent to patient movement on a treadmill with a speed of 4.5 miles to 5 miles per hour [21]. Activity levels above this threshold were deemed to have negatively impacted signal quality for the purposes of our validation analysis. Data from participants with an index score ≥2.4 g/s were removed from the study [21].

Michael H Hugh McGillion, Nazari Dvirnik, Stephen Yang, Emilie Belley-Côté, Andre Lamy, Richard Whitlock, Maura Marcucci, Flavia K Borges, Emmanuelle Duceppe, Carley Ouellette, Marissa Bird, Sandra L Carroll, David Conen, Jean-Eric Tarride, Prathiba Harsha, Ted Scott, Amber Good, Krysten Gregus, Karla Sanchez, Pamela Benoit, Julian Owen, Valerie Harvey, Elizabeth Peter, Jeremy Petch, Jessica Vincent, Michelle Graham, P J Devereaux

JMIR Mhealth Uhealth 2022;10(2):e24916

An Activity Tracker–Guided Physical Activity Program for Patients Undergoing Radiotherapy: Protocol for a Prospective Phase III Trial (OnkoFit I and II Trials)

An Activity Tracker–Guided Physical Activity Program for Patients Undergoing Radiotherapy: Protocol for a Prospective Phase III Trial (OnkoFit I and II Trials)

FACT-G: Functional Assessment of Cancer Therapy-General; RT: radiotherapy. After providing informed consent, patients will be included into either the Onko Fit I trial or Onko Fit II trial and randomized into 1 of the 3 arms of the studies (Figure 1). Both studies aim to include 201 subjects each. In this arm, patients will be advised to conduct at least 1.5 hours of moderate physical activity or 75 minutes of strenuous physical activity per week.

Franziska Hauth, Barbara Gehler, Andreas Michael Nieß, Katharina Fischer, Andreas Toepell, Vanessa Heinrich, Inka Roesel, Andreas Peter, Mirjam Renovanz, Andreas Hartkopf, Andreas Stengel, Daniel Zips, Cihan Gani

JMIR Res Protoc 2021;10(9):e28524